The secondary sources include annual reports, press releases, investor presentations of companies, white papers, journals, certified publications, and articles from recognized authors, directories, and databases
Current formulations of GLP-1 analogs rely primarily on subcutaneous injections, which may pose challenges to patient convenience and long-term adherence
GLP-1 medications have been getting a lot of attention in recent yearsand for good reason
studies have shown a significant portion of patients lose less than 5% of their body weight on the drug, though they may experience other metabolic improvements
When you take expired medication, you cannot be sure of its safety or effectiveness
For most patients, the most effective longterm strategy after achieving a target weight is to continue GLP1 treatment